Logo image of DHB.CA

DELIVRA HEALTH BRANDS INC (DHB.CA) Stock Fundamental Analysis

TSX-V:DHB - TSX Venture Exchange - CA24703H1029 - Common Stock - Currency: CAD

0.16  0 (0%)

Fundamental Rating

4

Overall DHB gets a fundamental rating of 4 out of 10. We evaluated DHB against 35 industry peers in the Pharmaceuticals industry. While DHB seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, DHB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year DHB has reported negative net income.
In the past year DHB had a positive cash flow from operations.
In the past 5 years DHB reported 4 times negative net income.
DHB had negative operating cash flow in 4 of the past 5 years.
DHB.CA Yearly Net Income VS EBIT VS OCF VS FCFDHB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.07%, DHB is in the better half of the industry, outperforming 78.38% of the companies in the same industry.
DHB's Return On Equity of 0.14% is fine compared to the rest of the industry. DHB outperforms 78.38% of its industry peers.
Industry RankSector Rank
ROA 0.07%
ROE 0.14%
ROIC N/A
ROA(3y)-17.82%
ROA(5y)-68.21%
ROE(3y)-64.91%
ROE(5y)-143.71%
ROIC(3y)N/A
ROIC(5y)N/A
DHB.CA Yearly ROA, ROE, ROICDHB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With a decent Profit Margin value of 0.05%, DHB is doing good in the industry, outperforming 78.38% of the companies in the same industry.
Looking at the Gross Margin, with a value of 51.21%, DHB is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
DHB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.05%
GM 51.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.66%
GM growth 5Y9.71%
DHB.CA Yearly Profit, Operating, Gross MarginsDHB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

DHB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DHB has been increased compared to 1 year ago.
Compared to 5 years ago, DHB has less shares outstanding
DHB has a worse debt/assets ratio than last year.
DHB.CA Yearly Shares OutstandingDHB.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
DHB.CA Yearly Total Debt VS Total AssetsDHB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -21.44, we must say that DHB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -21.44, DHB is not doing good in the industry: 83.78% of the companies in the same industry are doing better.
The Debt to FCF ratio of DHB is 5.29, which is a neutral value as it means it would take DHB, 5.29 years of fcf income to pay off all of its debts.
DHB's Debt to FCF ratio of 5.29 is amongst the best of the industry. DHB outperforms 81.08% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that DHB is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.44, DHB perfoms like the industry average, outperforming 48.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 5.29
Altman-Z -21.44
ROIC/WACCN/A
WACC8.49%
DHB.CA Yearly LT Debt VS Equity VS FCFDHB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 3.49 indicates that DHB has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.49, DHB belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
A Quick Ratio of 2.84 indicates that DHB has no problem at all paying its short term obligations.
DHB's Quick ratio of 2.84 is amongst the best of the industry. DHB outperforms 91.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 2.84
DHB.CA Yearly Current Assets VS Current LiabilitesDHB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

DHB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.78%, which is quite impressive.
Looking at the last year, DHB shows a quite strong growth in Revenue. The Revenue has grown by 10.41% in the last year.
Measured over the past years, DHB shows a quite strong growth in Revenue. The Revenue has been growing by 15.66% on average per year.
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-940%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y15.85%
Revenue growth 5Y15.66%
Sales Q2Q%34.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
DHB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.49% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12%
Revenue Next 2Y13.49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
DHB.CA Yearly Revenue VS EstimatesDHB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
DHB.CA Yearly EPS VS EstimatesDHB.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DHB.CA Price Earnings VS Forward Price EarningsDHB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

75.68% of the companies in the same industry are more expensive than DHB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.29
EV/EBITDA N/A
DHB.CA Per share dataDHB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DHB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DELIVRA HEALTH BRANDS INC

TSX-V:DHB (3/7/2025, 7:00:00 PM)

0.16

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04 2025-03-04
Earnings (Next)05-13 2025-05-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.63%
Ins Owner ChangeN/A
Market Cap5.00M
Analysts84.44
Price Target0.92 (475%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)900%
PT rev (3m)900%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF 12.29
P/OCF 12.29
P/B 1.16
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.01
FCFY8.14%
OCF(TTM)0.01
OCFY8.14%
SpS0.4
BVpS0.14
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.05%
GM 51.21%
FCFM 3.24%
ROA(3y)-17.82%
ROA(5y)-68.21%
ROE(3y)-64.91%
ROE(5y)-143.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.66%
GM growth 5Y9.71%
F-Score6
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 5.29
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 6783.33%
Current Ratio 3.49
Quick Ratio 2.84
Altman-Z -21.44
F-Score6
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)1.34%
Cap/Depr(5y)42.2%
Cap/Sales(3y)0.22%
Cap/Sales(5y)16.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-940%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.41%
Revenue growth 3Y15.85%
Revenue growth 5Y15.66%
Sales Q2Q%34.34%
Revenue Next Year12%
Revenue Next 2Y13.49%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-487.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1280.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y122.24%
OCF growth 3YN/A
OCF growth 5YN/A